Teva's first ever National Forum for Bio-Innovators gathers in Tel Aviv - The Jerusalem Post
Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net
Is Biogen stock a buy after Teva settled the Vumerity patent lawsuit? - Rich Picks Daily
Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive | FiercePharma
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Teva Castel - Dizengoff - Tel Aviv Health Store - HappyCow
Teva Castel - Dizengoff - Tel Aviv Health Store - HappyCow
Teva CFO hopes for growth in 2022 - Globes
Teva Chooses New Israeli Headquarters in Tel Aviv | Ctech